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ISSNBackground: Cytomegalovirus (CMV) retinitis is a major cause of visual impairment
and blindness among patients with uncontrolled HIV infections. Whereas polymor-
phisms in interferon-lambda 3 (IFNL3, previously named IL28B) strongly influence the
clinical course of hepatitis C, few studies examined the role of such polymorphisms in
infections due to viruses other than hepatitis C virus.
Objectives: To analyze the association of newly identified IFNL3/4 variant
rs368234815with susceptibility to CMV-associated retinitis in a cohort of HIV-infected
patients.
Design and methods: This retrospective longitudinal study included 4884 white
patients from the Swiss HIV Cohort Study, among whom 1134 were at risk to develop
CMV retinitis (CD4þ nadir <100 /ml and positive CMV serology). The association of
CMV-associated retinitis with rs368234815 was assessed by cumulative incidence
curves and multivariate Cox regression models, using the estimated date of HIV
infection as a starting point, with censoring at death and/or lost follow-up.
Results: A total of 40 individuals among 1134 patients at risk developed CMV retinitis.
The minor allele of rs368234815was associated with a higher risk of CMV retinitis (log-
rank test P¼0.007, recessive mode of inheritance). The association was still significant
in a multivariate Cox regression model (hazard ratio 2.31, 95% confidence interval
1.09–4.92, P¼0.03), after adjustment for CD4þ nadir and slope, HAART and HIV-risk
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1886 AIDS 2014, Vol 28 No 13Conclusion: We reported for the first time an association between an IFNL3/4 polymor-
phism and susceptibility to AIDS-related CMV retinitis. IFNL3/4may influence immunity
against viruses other than HCV.  2014 Wolters Kluwer Health | Lippincott Williams & WilkinsAIDS 2014, 28:1885–1889Keywords: AIDS, cytomegalovirus retinitis, HIV, IFNL3, immunogenetics,
polymorphismIntroduction
Cytomegalovirus (CMV) retinitis is a major cause of visual
impairment and blindness among patients with uncon-
trolled HIV infections, insufficient drug compliance or
therapy intolerance [1]. The disease is characterized by
progressive necrosis that can lead to retinal detachment,
optic atrophy and finally loss of vision [2–4].
Although individuals can remain asymptomatic for
extended periods of time with low CD4þ cell counts,
others rapidly develop retinitis when their CD4þ cell
count drops below 50–100 CD4þ cells/ml. Such
differences in the onset and/or susceptibility of the
disease may be partly due to host genetic factors. Among
African Americans, a promoter haplotype within C-C
chemokine receptor type 5 (CCR5) and a polymorphism
in the stromal cell-derived factor 1 (SDF1) were
associated with increased risk of retinitis progression
[5,6]. In white patients, different haplotypes of the
interleukin (IL)-10 receptor subunit 1 (IL10-R1) [5] and
polymorphisms within tumor necrosis factor (TNF) [7]
were linked to susceptibility to CMV retinitis.
Interferon-lambda 3 (IFNL3) (previously designated as
IL28B) belongs to the type III IFN family and was
reported as a major determinant of hepatitis C virus
(HCV) clearance. A TT/-G substitution (rs368234815)
introducing a frameshift in the DNA sequence was shown
to be the best marker of HCV clearance [8,9]. The minor
-G allele was recently associated with the expression of a
novel IFN-like protein called IFNL4 [8]. We showed that
this allele was also associated with reduced IFNL3
expression [8,9]. So far, only a few studies examined
whether IFNL3/4 polymorphisms influence immune
responses against viruses other than HCV [10–12]. We
examined the role of this polymorphism in the
development of CMV retinitis among patients from
the Swiss HIV Cohort Study (SHCS).Material and methods
Study patients
Patients were included from the Swiss HIVCohort Study,
an ongoing multicenter prospective study of HIV-
infected patients enrolled at seven major Swiss hospitalspincott Williams & Wilkins. Unauthoand their local affiliated centers since 1988.White patients
with available samples for DNA extraction, written con-
sent for genetic studies and a CD4þ nadir below 400/ml
were selected. Demographic characteristics including age,
duration of HIV infection, sex, CD4þ T-cell count nadir,
otheropportunistic infections,HIVmaximal viral load and
HAART use were extracted from clinical databases.
Patients at risk to develop CMV retinitis were defined
as those with a positive CMV serology and a CD4þ T-cell
nadir below 100/ml. CMV retinitis was defined by
characteristic ophthalmoscopic findings (discrete patches
of retinal whitening with distinct borders speeding in a
centrifugal manner, frequently associated with retinal
vasculitis, hemorrhage and necrosis) followed by evidence
of response toCMVtreatment (residual retinal scarring and
atrophy with retinal pigment epithelial mottling). The
disease was considered presumptive unless proven by a
positive CMV PCR detection.
Single-nucleotide polymorphism genotyping
Genomic DNAs isolated either from blood or cell pellets
were genotyped using a customized Golden Gate Geno-
typing Assay on Veracode platform (Illumina, San Diego,
California, USA) or a Competitive Allele Specific PCR
(KASP) system (LGC Genomics, former KBioscience,
Hoddesdon, Herts, UK; http://www.lgcgenomics.com/
kaspchallenge).
Statistical analysis
Statistical analyses were performed using Stata (version
13.1; StataCorp LP, College Station, Texas, USA).
Hardy–Weinberg equilibrium test was assessed using
the program genhw, implemented in Stata. The
association of IFNL3/4 polymorphism with CMV
retinitis for the additive, dominant and recessive modes
of inheritance was assessed by cumulative incidence
curves (i.e. 1 minus Kaplan–Meier to estimate the
cumulative probability of retinitis), using the estimated
date of HIV infection as a starting point, with censoring
at death and/or lost follow-up. Proportional hazard
assumption was verified by using the stphtest command
implemented in Stata. Estimated dates of HIV infection
and CD4þ slopes (rate of CD4þ depletion in the absence
of HAART) in both incident and prevalent cases were
obtained by using a joint back calculation model, as
described previously [13]. The CD4þ nadir square root
was used to obtain a normally distributed variable. The
association between CMV retinitis and genetic variablesrized reproduction of this article is prohibited.
IFNL3/4 polymorphism and cytomegalovirus retinitis Bibert et al. 1887was first assessed using the log-rank test. Demographic
and clinical factors that were potentially associated with
CMV retinitis were then analyzed in univariate and
multivariate Cox regression models. Stepwise (i.e.
backward) regression (P< 0.2) was used to determine
which variables were independently associated with
the endpoint.Results
The study included 4884 white patients with consent for
host genetic studies from the SHCS, among whom 1134
were at risk of developing CMV retinitis (CD4þ nadir
<100 /ml and positive CMV serology; Supplementary
Table 1, http://links.lww.com/QAD/A544). In this
high-risk group, most patients were male (78%) and
the most frequent risk factors for HIV infection included
homosexual contact (43%), heterosexual contact (32%)
and drug use (21%). The median age at estimated time of
HIV infection was 31 years [interquartile range (IQR)
14]. The median CD4þ T-cell count nadir and CD4þ
slopes were 39.5/ml (IQR 47) and 2.66 (IQR 0.97),
respectively. CMV retinitis was diagnosed in 40/1134
individuals (29 proven and 11 presumptive).
Patients who carried two copies of the minor -G allele of
IFNL3/4 rs368234815 polymorphisms had a signifi-
cantly higher cumulative incidence of CMV retinitis (log-
rank test P¼ 0.007; Fig. 1). The association was still
significant in a multivariate Cox regression model [hazard
ratio 2.31, 95% confidence interval (CI) 1.09–4.92,Copyright © Lippincott Williams & Wilkins. Unaut
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Fig. 1. Cumulative incidence curves (i.e. 1 minus Kaplan–Meier-es
IFNL3/4 rs368234815 polymorphism. The estimated date of HIV i
or lost follow-up.P¼ 0.03]. Covariates that remained in the model after
stepwise (backward) selection were the CD4þ cell count
nadir square root (hazard ratio 0.73, 95% CI 0.64–0.84,
P< 0.001), the CD4þ slope (hazard ratio 0.73, 95% CI
0.49–1.07, P¼ 0.11), the use of HAART (hazard ratio
0.40, 95% CI 0.18–0.88, P¼ 0.02), as well as the HIV
transmission mode (heterosexual contact, hazard ratio
0.51, 95%CI 0.23–1.09, P¼ 0.08; intravenous (i.v.) drug
use, hazard ratio 0.35, 95% CI 0.13–0.93, P¼ 0.04, using
MSM as reference; Table 1 and Supplementary Table 2,
http://links.lww.com/QAD/A544).Discussion
Polymorphisms in IFNL3/4 have a dramatic influence on
HCV clearance, either spontaneously or in response to
IFN-base therapy [8,9]. Few studies examined whether
these polymorphisms influence susceptibility to other
viral pathogens. In this study, we report an associa-
tion between the newly identified IFNL3/4 mutant
rs368234815 allele and susceptibility to CMV retinitis
among HIV-infected patients.
The association between the rs368234815 polymorphism
and susceptibility to CMV retinitis is consistent with
studies performed in the field of hepatitis C, as the same
allele was associated with reduced HCV clearance, either
spontaneously or after IFN-based treatment. In addition,
we recently showed that this polymorphism is associated
with increased CMV infection in a cohort of 1021 solid
organ transplant recipients [14]. This suggests that IFNLshorized reproduction of this article is prohibited.
TT/TT or TT/–G, reference
–G/–G, P = 0.007
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Table 1. Independent risk factors associated with cytomegalovirus retinitis.
Variable
Univariate Multivariate
HR (95% CI)a P HR (95% CI)b P
Sex 0.72 (0.32–1.64) 0.44
Age at estimated date of infection (continuous) 1.00 (0.97–1.03) 0.99
CD4þ nadir (sqrt transformed, continuous) 0.71 (0.63–0.81) <0.001 0.73 (0.64–0.84) <0.001
CD4þ slope (continuous) 0.64 (0.45–0.92) 0.01 0.73 (0.49–1.07) 0.11
Maximal HIV RNA load (continuous) 1.38 (0.87–2.17) 0.17
HAART (time-dependent covariate)a 0.48 (0.24–0.97) 0.04 0.40 (0.18–0.88) 0.02
Risk factors
MSM Ref.
Hetero 0.57 (0.27–1.20) 0.14 0.51 (0.23–1.09) 0.08
Drug user 0.40 (0.15–1.06) 0.06 0.35 (0.13–0.93) 0.04
Other 0.53 (0.07–3.93) 0.54
HCV coinfection 1.03 (0.55–1.93) 0.92
Active HBV infection 0.88 (0.21–3.63) 0.86
IFNL3 rs368234815 (-G/-G versus TT/TT or TT/-G) 2.59 (1.26–5.29) 0.009 2.31 (1.09–4.92) 0.03
Stepwise (i.e. backward) regression (P<0.2) was used to determine which variables were independently associated with the endpoint. CI,
confidence interval; HBV, hepatitis B virus; HCV, hepatitis C virus; HR, hazard ratio.
aThe proportional hazard assumption was verified for all variables with the exception of HAART (P¼0.03 in the univariate model, P¼0.04 in the
multivariate model). However, the association between IFNL3 rs368234815 and CMV retinitis was similar when HAART was removed from the
multivariate model (HR 2.53, 95% CI 1.20–5.35, P¼0.015) (see supplementary Table 2, http://links.lww.com/QAD/A544).
bThe association between rs368234815 and CMV retinitis was still significant when anti-CMV treatment was added into the model (HR 2.55, 95%
CI 1.20–5.43, P¼0.015).may be involved in the immune response to an extended
range of viral pathogens.
Whereas the functional relevance of this association
remains to be elucidated, increasing evidences suggest
a role for IFNLs in the immune response against
herpesviruses, including CMV. Immune cells can detect
CMV by using two main families of pattern recognition
receptors – the toll-like receptors (TLR2, TLR3, TLR7,
TLR8, TLR9) and the RIG-like receptors (Melanoma
Differentiation-Associated protein 5 (MDA5) and reti-
noic acid-inducible gene 1 (RIG-I)), which lead to the
production of IFNs. IFNs promote the induction of IFN-
stimulated genes (ISGs) which were shown to exert
antiviral activities against a broad range of viruses. For
instance, colonic cells from mice infected with murine
CMV were shown to produce increased amounts
of IFNLs [15]. In turn, IFNLs up-regulated STAT1
phosphorylation and ISG production in different human
intestinal epithelial cells which results in an increased IFN
response due to the expression of ISGs [15]. Recent
studies using different models of CMV retinitis high-
lighted the role of IFNs in the development of Th1
immune responses [16,17] and the contribution of IFNL3
in the regulation of T-cell function and natural killer
(NK)-cell cytotoxicity [18].
The rs368234815 polymorphism was shown to influence
both IFNL3 and IFN-g-inducible protein 10 (IP-10)
mRNA expression in peripheral blood mononuclear cells
(PBMCs) stimulated with Poly(I:C) and to promote the
expression of IFNL4 [8,9]. Thus, increased susceptibility
to retinitis in individuals carrying the polymorphismsmay
result from insufficient IFNL3 and/or the production ofpyright © Lippincott Williams & Wilkins. UnauthoIFNL4. Yet, the mechanisms by which IFNL4 (a cytokine
predicted to exert antiviral activities) can be associated
with increased susceptibility to viral infections has still not
been elucidated [19].
Like most genetic association studies, our study has several
limitations. Whereas the diagnosis of CMV retinitis is
based on stringent clinical and laboratory criteria, the
diagnosis of CMV disease is ill-defined, and its association
with IFNL3/4 polymorphisms was not analyzed in this
study. Whereas most cases of CMV retinitis were
diagnosed as proven (PCR-documented), a few cases
were classified as presumptive (based on a positive CMV
serology and a typical clinical presentation diagnosed
by an ophthalmologist). Finally, the number of CMV
retinitis patients carrying the risk genotype was relatively
small. Further studies are needed to replicate the
association reported in this study, and additional work
is needed to understand the biological role of IFLNs in
CMV retinitis.Acknowledgements
The authors thank all patients from the SHCS, as well as
collaborators from the clinical, laboratory and data centers
and all study nurses.
The project was supported by SHCS project No 613. The
SHCS is supported by the Swiss National Foundation
(SNF grant No 33CS30_148522) and by the SHCS
research foundation.rized reproduction of this article is prohibited.
IFNL3/4 polymorphism and cytomegalovirus retinitis Bibert et al. 1889Author’s contributions: S.B. performed sample manage-
ment, DNA extraction, candidate SNP genotyping and
wrote the manuscript.
A.W. performed SNP genotyping for the SHCS patients
and data management.
P.T. contributed to statistical analyses.
M.C. and O.M. contributed to study design and
manuscript writing.
Members of the SHCS group including E.B., H.F.,
H.F.G., M.H., L.K., M.O., and M.C. were directly
involved in the follow-up of SHCS patients and case
report forms management.
P.Y.B. designed the SHCS genetic project, obtained
funding, supervised genotyping, performed data manage-
ment and statistical analysis and wrote the manuscript.
All authors critically revised the manuscript.
The members of the Swiss HIV Cohort Study are: J.
Barth, M. Battegay, E. Bernasconi, J. Bo¨ni, H.C. Bucher,
C. Burton-Jeangros, A. Calmy, M. Cavassini, C. Cellerai,
M. Egger, L. Elzi, J. Fehr, J. Fellay, M. Flepp, P. Francioli,
H. Furrer, C.A. Fux, M. Gorgievski, H. Gu¨nthard, D.
Haerry, B. Hasse, H.H. Hirsch, B. Hirschel, I. Ho¨sli, C.
Kahlert, L. Kaiser, O. Keiser, C. Kind, T. Klimkait, H.
Kovari, B. Ledergerber, G. Martinetti, B. Martinez de
Tejada, K. Metzner, N. Mu¨ller, D. Nadal, G. Pantaleo, A.
Rauch, S. Regenass, M. Rickenbach, C. Rudin, P.
Schmid, D. Schultze, F. Scho¨ni-Affolter, J. Schu¨pbach, R.
Speck, A. Telenti, A. Trkola, P. Vernazza, R. Weber,
S. Yerly.
Conflicts of interest
P.Y.B. is supported by the Swiss National Foundation
(320030_144054), the Leenaards Foundation, the Santos-
Suarez Foundation and the Loterie Romande. P.Y.B. is
recipient of a Me´rieux research grant.References
1. Heiden D, Ford N, Wilson D, Rodriguez WR, Margolis T,
Janssens B, et al. Cytomegalovirus retinitis: the neglected dis-
ease of the AIDS pandemic. PLoS Med 2007; 4:e334.
2. Jabs DA. Ocular manifestations of HIV infection. Trans Am
Ophthalmol Soc 1995; 93:623–683.Copyright © Lippincott Williams & Wilkins. Unaut3. Jabs DA, Van Natta ML, Holbrook JT, Kempen JH, Meinert CL,
Davis MD, et al. Longitudinal study of the ocular complications
of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology
2007; 114:780–786.
4. Jacobson MA, Stanley H, Holtzer C, Margolis TP, Cunningham
ET. Natural history and outcome of new AIDS-related cyto-
megalovirus retinitis diagnosed in the era of highly active
antiretroviral therapy. Clin Infect Dis 2000; 30:231–233.
5. Sezgin E, Jabs DA, Hendrickson SL, Van Natta M, Zdanov A,
Lewis RA, et al. Effect of host genetics on the development of
cytomegalovirus retinitis in patients with AIDS. J Infect Dis
2010; 202:606–613.
6. Sezgin E, vanNattaML, Ahuja A, Lyon A, Srivastava S, Troyer JL,
et al. Association of host genetic risk factors with the course
of cytomegalovirus retinitis in patients infected with human
immunodeficiency virus. Am J Ophthalmol 2011; 151:999–
1006e1004.
7. Deghaide NH, Rodrigues Mde L, Castelli EC, Mendes-Junior CT,
Figueiredo JF, Donadi EA. Tumor necrosis factor region poly-
morphisms are associated with AIDS and with cytomegalovirus
retinitis. AIDS 2009; 23:1641–1647.
8. Prokunina-Olsson L, Muchmore B, TangW, Pfeiffer RM, Park H,
Dickensheets H, et al. A variant upstream of IFNL3 (IL28B)
creating a new interferon gene IFNL4 is associated with im-
paired clearance of hepatitis C virus. Nat Genet 2013; 45:164–
171.
9. Bibert S, Roger T, Calandra T, Bochud M, Cerny A, Semmo N,
et al. IL28B expression depends on a novel TT/-G polymorph-
ism which improves HCV clearance prediction. J Exp Med
2013; 210:1109–1116.
10. Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan
SR. Lambda interferon (IFN-lambda), a type III IFN, is induced
by viruses and IFNs and displays potent antiviral activity
against select virus infections in vivo. J Virol 2006; 80:4501–
4509.
11. AnkN, IversenMB, Bartholdy C, Staeheli P, Hartmann R, Jensen
UB, et al. An important role for type III interferon (IFN-
lambda/IL-28) in TLR-induced antiviral activity. J Immunol
2008; 180:2474–2485.
12. Schneider K, Meyer-Koenig U, Hufert FT. Human cytomegalo-
virus impairs the function of plasmacytoid dendritic cells in
lymphoid organs. PLoS One 2008; 3:e3482.
13. Taffe P, May M, Swiss HIVCS. A joint back calculation model
for the imputation of the date of HIV infection in a prevalent
cohort. Stat Med 2008; 27:4835–4853.
14. Manuel O,Wojtowicz A, Bibert S, Kralidis G, Egli A, Mueller N,
et al. IL28B Polymorphisms influence cytomegalovirus viremia
in solid organ transplant recipients. American Transplant Con-
gress, Seattle May 18–22, 2013.
15. Brand S, Beigel F, Olszak T, Zitzmann K, Eichhorst ST, Otte JM,
et al. IL-28A and IL-29 mediate antiproliferative and antiviral
signals in intestinal epithelial cells and murine CMV infection
increases colonic IL-28A expression. Am J Physiol Gastrointest
Liver Physiol 2005; 289:G960–968.
16. Takase H, Futagami Y, Yoshida T, Kamoi K, Sugita S, Imai Y,
et al. Cytokine profile in aqueous humor and sera of patients
with infectious or noninfectious uveitis. Invest Ophthalmol Vis
Sci 2006; 47:1557–1561.
17. Iyer JV, Connolly J, Agrawal R, Yeo TK, Lee B, Au B, et al.
Cytokine analysis of aqueous humor in HIV patients with
cytomegalovirus retinitis. Cytokine 2013; 64:541–547.
18. Bigger JE, Thomas CA 3rd, Atherton SS. NK cell modulation of
murine cytomegalovirus retinitis. J Immunol 1998; 160:5826–
5831.
19. Hamming OJ, Terczynska-Dyla E, Vieyres G, Dijkman R,
Jorgensen SE, Akhtar H, et al. Interferon lambda 4 signals via
the IFNlambda receptor to regulate antiviral activity against
HCV and coronaviruses. EMBO J 2013; 32:3055–3065.horized reproduction of this article is prohibited.
